Skip to main content

IRLAB Therapeutics

Göteborg, Sweden

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

$11.0M raised
May 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IRLAB Therapeutics

How much funding has IRLAB Therapeutics raised?
IRLAB Therapeutics has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are IRLAB Therapeutics's investors?
IRLAB Therapeutics's investors include Michael J. Fox Foundation, New Leaf Venture Partners, EISMEA, Fenja Capital, Marinvest Holding.
Where is IRLAB Therapeutics headquartered?
IRLAB Therapeutics is headquartered in Göteborg, Sweden.
What does IRLAB Therapeutics do?
IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
What stage is IRLAB Therapeutics at?
IRLAB Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"IRLAB Therapeutics — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/irlab-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). IRLAB Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/irlab-therapeutics
Wikipedia (cite web)
{{cite web |title=IRLAB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/irlab-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .